NIH Bioimaging Institute Proposal Lacks "Compelling Argument" - Varmus
This article was originally published in The Gray Sheet
The need for a new bioimaging institute within the National Institutes for Health has not been adequately demonstrated, NIH Director Harold Varmus told the House Appropriations/Labor-HHS Subcommittee March 27.
You may also be interested in...
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.